NCT03565861View on ClinicalTrials.gov

Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 6, 2018

Primary Completion Date

September 2, 2018

Study Completion Date

October 10, 2018

Conditions
Safety Issues
Interventions
DRUG

Placebo

Intravenous vehicle

DRUG

NP10679

NP10679

Trial Locations (1)

21201

Pharmaron CPC, Baltimore

Sponsors

Lead Sponsor

Neurop Inc.
All Listed Sponsors
lead

Neurop Inc.

INDUSTRY

NCT03565861 - Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers | Biotech Hunter | Biotech Hunter